Among these DMCs, eight out of nine (88.9%) were found to be hypomethylated, while only one hypermethylated CpG site was identified in mt-ND2 in the plasma cfDNA of AD patients (Figure 2C). The gene discussed is MT-ND2; the disease is Alzheimer disease.